![]() |
市場調査レポート
商品コード
1635554
神経血管血栓除去装置市場:セグメント別規模、シェア、法規制、償還、手技、2036年までの予測Neurovascular Thrombectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2036 |
||||||
カスタマイズ可能
適宜更新あり
|
神経血管血栓除去装置市場:セグメント別規模、シェア、法規制、償還、手技、2036年までの予測 |
出版日: 2024年11月15日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
![]() |
神経血管血栓除去装置は、急性虚血性脳卒中の際に神経血管内の血栓を除去するために使用されます。ステントリトリーバーと吸引カテーテルの2種類があります。これらの器具は単独で使用することも、組み合わせて使用することもできます。ステントリトリーバーと吸引カテーテルは、それぞれ単独で使用することも、組み合わせて使用することもできるが、臨床成績と血行再建率は同等です。
当レポートは、世界の神経血管血栓除去装置市場について詳細に考察し、市場における競合情勢、SWOT分析、2036年までの市場予測、地域、国別の動向などを提供しています。
Neurovascular Thrombectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.
Neurovascular thrombectomy devices are used for the removal of a blood clot in the neurovascular vessels during an acute ischemic stroke. The two types of devices are stent retrievers and aspiration catheters. These devices can be used individually or in combination. While the clinical outcomes and revascularization rates is similar for both the device, used separately or in conjugation, the aspiration retriever is quicker and easier to operate and is therefore becoming more popular.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Neurovascular Thrombectomy Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Cerenovus, Medtronic Plc, Phenox GmbH, Terumo Neuro, Stryker Corp, Imperative Care Inc, Rapid Medical, Penumbra Inc, MicroPort Scientific Corp and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -